High Risk Prostate Cancer: Surgery vs. Radiation | Genomic Tests | Mark Scholz, MD | PCRI

High Risk Prostate Cancer: Surgery vs. Radiation | Genomic Tests | Mark Scholz, MD | PCRI

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRIПодробнее

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI

Gleason 9 & 10 Prostate Cancer: Cure Rates, Treatments, New Approaches | Mark Scholz, MD | PCRIПодробнее

Gleason 9 & 10 Prostate Cancer: Cure Rates, Treatments, New Approaches | Mark Scholz, MD | PCRI

A Medical Oncologist Compares Surgery and Radiation for Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

A Medical Oncologist Compares Surgery and Radiation for Prostate Cancer | Mark Scholz, MD | PCRI

Radiation and Hormone Therapy | Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

Radiation and Hormone Therapy | Prostate Cancer | Mark Scholz, MD | PCRI

Active Surveillance in 2022 | Laurence Klotz, MD | PCRIПодробнее

Active Surveillance in 2022 | Laurence Klotz, MD | PCRI

New Study Shows The Impact of Diet on Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

New Study Shows The Impact of Diet on Prostate Cancer | Mark Scholz, MD | PCRI

Decipher, SelectMDx, and 4K Score in Active Surveillance & Intermediate Prostate Cancer | PCRIПодробнее

Decipher, SelectMDx, and 4K Score in Active Surveillance & Intermediate Prostate Cancer | PCRI

Treating High-Risk Gleason 8: A Modern Approach | Mark Scholz, MD | PCRIПодробнее

Treating High-Risk Gleason 8: A Modern Approach | Mark Scholz, MD | PCRI

Radiation vs. Surgery for Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDПодробнее

Radiation vs. Surgery for Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

Новости